{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:29:23Z","timestamp":1787020163432,"version":"build-2736575974"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T00:00:00Z","timestamp":1635465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T00:00:00Z","timestamp":1635465600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The incidence of eclampsia and its adverse maternal outcomes are very high in developing countries, particularly in Subsaharan African Countries. Identifying predictors for adverse maternal outcomes of eclampsia has paramount importance for helping health care providers to optimize their management outcomes. Therefore, this study aimed to assess the incidence of adverse maternal outcomes of eclampsia and its determinant factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective follow-up study design was applied. The data were extracted from patient charts using a structured, pre-tested, questionnaire. Descriptive analyses (frequencies, means, and standard deviation) were calculated, and bi-variable and multivariable logistic regression models were used to testing the association between independent variables and an outcome variable. After the data were coded and entered into Epi-Info Version 7.2 Software, the data were analyzed using STATA Version 14 Statistical Software.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The magnitude of eclampsia was 5.36 per 1000 pregnancies (95% CI: 4.72, 6.10). The incidence of adverse maternal outcomes in eclamptic mothers was 53.7% (95% CI: 47.02, 60.24%). After adjusting for covariates maternal age 30\u201334, AOR 5.4 [95% CI\u2009=\u20091.02, 28.6]; age above 34, AOR 10.5 [95% CI\u2009=\u20091.3, 88.6]; gravidity 2\u20134, AOR 0.3 [95% CI\u2009=\u20090.1, 0.9]; 10 or more convulsions, AOR 4.6 [95% CI\u2009=\u20091.4, 14.9]; mild pyrexia, AOR 20.4 [95% CI\u2009=\u20093.7, 112.7]; moderate pyrexia, AOR 14.6 [95% CI\u2009=\u20091.7125.1]; platelet count below 50,000 cells\/mm\n                      <jats:sup>3<\/jats:sup>\n                      , AOR 34.9 [95% CI\u2009=\u20093.6, 336.2]; platelet count between 50,000 and 99,000 cells\/mm\n                      <jats:sup>3<\/jats:sup>\n                      , AOR 24.5 [95%CI\u2009=\u20095.4111.6]; and stillbirth of the current pregnancy, AOR 23.2 [95%CI\u2009=\u20092.1257.5] were strong predictors of adverse maternal outcomes in eclamptic mothers.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The incidence of adverse maternal outcomes of eclampsia was found to be high compared to similar studies discussed in this study. This study recommends early identification of patients with the risk factors (having many convulsions, high body temperature, low platelet count, patient age above 30\u2009years, and 2\u20134 pregnancies), strengthening the referral system, and advocation of research on the area of adverse maternal outcomes and thereby encourage evidence-based medicine.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12884-021-04199-1","type":"journal-article","created":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T01:02:33Z","timestamp":1635469353000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Incidence and determinants of adverse outcomes among women who were managed for eclampsia in the University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia"],"prefix":"10.1186","volume":"21","author":[{"given":"Yisfa","family":"Getaneh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elfalet","family":"Fekadu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adamu Takele","family":"Jemere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zelalem","family":"Mengistu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gebrekidan Ewnetu","family":"Tarekegn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Oumer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,29]]},"reference":[{"key":"4199_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejogrb.2013.05.005","volume":"170","author":"E Abalos","year":"2013","unstructured":"Abalos E, Cuesta C, Grosso AL, Chou D, Say L. Global and regional estimates of preeclampsia and eclampsia: a systematic review. Eur J Obstet Gynecol Reprod Biol. 2013;170:1\u20137.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"Suppl 1","key":"4199_CR2","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/1471-0528.12629","volume":"121","author":"E Abalos","year":"2014","unstructured":"Abalos E, Cuesta C, Carroli G, Qureshi Z, Widmer M, Vogel JP, et al. Pre-eclampsia, eclampsia and adverse maternal and perinatal outcomes: a secondary analysis of the World Health Organization Multicountry Survey on Maternal and Newborn Health. Maternal and Newborn Health Research. BJOG. 2014;121(Suppl 1):14\u201324.","journal-title":"BJOG"},{"key":"4199_CR3","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1111\/j.1471-0528.2007.01423.x","volume":"114","author":"MO Knight","year":"2007","unstructured":"Knight MO. Eclampsia in the United Kingdom 2005. BJOG. 2007;114:1072\u20138.","journal-title":"BJOG"},{"key":"4199_CR4","doi-asserted-by":"publisher","unstructured":"Sharara H, Ummunnisa F, Aboobacker N, Al-Tamimi H. Changes in trends and outcomes of eclampsia: a success story from Qatar. Quatar Med J. 2019;2019(1):10. https:\/\/doi.org\/10.5339\/qmj.2019.10.","DOI":"10.5339\/qmj.2019.10"},{"key":"4199_CR5","first-page":"27","volume":"44","author":"M Abate","year":"2006","unstructured":"Abate M, Lakew Z. Eclampsia a 5 years retrospective review of 216 cases managed in two teaching hospitals in Addis Ababa. Ethiop Med J. 2006;44:27\u201331.","journal-title":"Ethiop Med J"},{"key":"4199_CR6","doi-asserted-by":"publisher","unstructured":"Wagnew M, Dessalegn M, Worku A, Nyagero J. Trends of preeclampsia\/eclampsia and maternal and neonatal outcomes among women delivering in Addis Ababa selected government hospitals, Ethiopia: a retrospective crosssectional study. Pan Afr Med J. 2016;25(Suppl 2):12. https:\/\/doi.org\/10.11604\/pamj.supp.2016.25.2.9716.","DOI":"10.11604\/pamj.supp.2016.25.2.9716"},{"key":"4199_CR7","doi-asserted-by":"publisher","first-page":"e323","DOI":"10.1016\/S2214-109X(14)70227-X","volume":"2","author":"L Say","year":"2014","unstructured":"Say L, Chou D, Gemmill A, Tuncalp O, Moller AB, Danels J, et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health. 2014;2:e323\u201333.","journal-title":"Lancet Glob Health"},{"issue":"Suppl 3","key":"4199_CR8","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1186\/1471-2458-11-S3-S8","volume":"11","author":"C Ronsmans","year":"2011","unstructured":"Ronsmans C, Campbell O. Quantifying the fall in mortality associated with interventions related to hypertensive diseases of pregnancy. BMC Public Health. 2011;11(Suppl 3):S8.","journal-title":"BMC Public Health"},{"key":"4199_CR9","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1080\/01443610410001645415","volume":"24","author":"AU El-Nafaty","year":"2004","unstructured":"El-Nafaty AU, Melah GS, Massa AA, Audu BM, Nelda M. The analysis of eclamptic morbidity and mortality in the specialist hospital Gombe, Nigeria. J Obstet Gynaecol. 2004;24:142\u20137.","journal-title":"J Obstet Gynaecol"},{"key":"4199_CR10","doi-asserted-by":"publisher","unstructured":"Mahran A, Fares H, Elkhateeb R, Ibrahim M, Bahaa H, Sadad A, et al. Risk factors and outcome of patients with eclampsia at a tertiary hospital in Egypt. BMC Pregnancy Childbirth. 2017;17(1):435. https:\/\/doi.org\/10.1186\/s12884-017-1619-7.","DOI":"10.1186\/s12884-017-1619-7"},{"key":"4199_CR11","first-page":"875","volume":"112","author":"D Tuffnell","year":"2005","unstructured":"Tuffnell D, Jankowicz D, Lindow S, Lyons G, Mason G, Russell I, et al. Outcomes of severe pre-eclampsia\/eclampsia in Yorkshire 1999\/2003. Obstet Gynecol. 2005;112:875\u201380.","journal-title":"Obstet Gynecol"},{"key":"4199_CR12","doi-asserted-by":"publisher","first-page":"111","DOI":"10.4314\/ejhs.v25i2.2","volume":"25","author":"R Das","year":"2015","unstructured":"Das R, Biswas S. Eclampsia: the major cause of maternal mortality in eastern India. Ethiop J Health Sci. 2015;25:111\u20136.","journal-title":"Ethiop J Health Sci"},{"key":"4199_CR13","doi-asserted-by":"publisher","unstructured":"Wassie AY, Anmut W. Prevalence of Eclampsia and its Maternal-fetal outcomes at Ghandi Memorial Hospital, Addis Ababa Ethiopia, 2019. Retrospective study. Int J Womens Health. 2021;13:231-7. https:\/\/doi.org\/10.2147\/IJWH.S298463.","DOI":"10.2147\/IJWH.S298463"},{"key":"4199_CR14","first-page":"123","volume":"8","author":"Jackson","year":"1970","unstructured":"Jackson, et al. Eclampsia in Addis Ababa: pattern and treatment. Ethiop Med J. 1970;8:123\u20138.","journal-title":"Ethiop Med J"},{"key":"4199_CR15","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1097\/AOG.0b013e31823311c1","volume":"118","author":"S Liu","year":"2011","unstructured":"Liu S, Joseph KS, Liston RM, Bartholomew S, Walker M, Le\u00f3n JA, et al. Maternal Health Study Group of Canadian Perinatal Surveillance. Incidence, risk factors, and associated complications of eclampsia. Obstet Gynecol. 2011;118:987\u201394.","journal-title":"Obstet Gynecol"},{"key":"4199_CR16","first-page":"9","volume":"61","author":"H Minakami","year":"2009","unstructured":"Minakami H, et al. Placental abruption, HELLP syndrome, and eclampsia in Japan. Nippon Sanka-Fujina Gakkai Zassh. 2009;61:9.","journal-title":"Nippon Sanka-Fujina Gakkai Zassh"},{"key":"4199_CR17","doi-asserted-by":"publisher","first-page":"3132","DOI":"10.3109\/14767058.2015.1114095","volume":"29","author":"R Chibber","year":"2016","unstructured":"Chibber R, Al-Hijji J, Amen A, Fouda M, Kaleemullah ZM, El-Saleh E, et al. Maternal and perinatal outcome of eclampsia over a decade at a tertiary hospital in Kuwait. J Matern Fetal Neonatal Med. 2016;29:3132\u20137.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"4199_CR18","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1080\/01443610601113961","volume":"27","author":"AA Sobande","year":"2007","unstructured":"Sobande AA, Eskandar M, Bahar A, Abusham A. Severe pre-eclampsia and eclampsia in Abha, the southwest region of Saudi Arabia. J Obstet Gynaecol. 2007;27:150\u20134.","journal-title":"J Obstet Gynaecol"},{"key":"4199_CR19","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.ijgo.2011.07.012","volume":"115","author":"A Gaym","year":"2011","unstructured":"Gaym A, Bailey P, Pearson L, Admasu K, Gebrehiwot Y. Disease burden due to pre-eclampsia\/eclampsia and the Ethiopian health system's response. Int J Gynecol Obstet. 2011;115:112\u20136.","journal-title":"Int J Gynecol Obstet"},{"key":"4199_CR20","doi-asserted-by":"publisher","first-page":"418","DOI":"10.4103\/TJOG.TJOG_45_19","volume":"36","author":"JE Mamah","year":"2019","unstructured":"Mamah JE, Onoh RC, Umeokonkwo CD, Onwe EO, Ezeonu PO, Okafor L. Severe preeclampsia and eclampsia: a 6-year review at the Federal Teaching Hospital, Abakaliki, Southeast Nigeria. Trop J Obstet Gynaecol. 2019;36:418.","journal-title":"Trop J Obstet Gynaecol"},{"key":"4199_CR21","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1186\/s13104-019-4334-9","volume":"12","author":"S Ngwenya","year":"2019","unstructured":"Ngwenya S, Jones B, Mwembe D. Determinants of adverse maternal and perinatal outcomes in severe preeclampsia and eclampsia in a low-resource setting, Mpilo Central Hospital, Bulawayo, Zimbabwe. BMC Res Notes. 2019;12:298.","journal-title":"BMC Res Notes"},{"key":"4199_CR22","doi-asserted-by":"publisher","first-page":"81","DOI":"10.4103\/1596-3519.56233","volume":"8","author":"AA Kullima","year":"2009","unstructured":"Kullima AA, Kawuwa MB, Audu BM, Usman H, Geidam AD. A 5-year review of maternal mortality associated with eclampsia in a tertiary institution in northern Nigeria. Ann Afr Med. 2009;8:81\u20134.","journal-title":"Ann Afr Med"},{"key":"4199_CR23","doi-asserted-by":"crossref","unstructured":"Taner CE, Hakverdi AU, Aban M, Erden AC, \u00d6zelbaykal U. Prevalence, management and outcome in eclampsia. Int J Gynaecol Obstet. 1996;53(1):11-5.","DOI":"10.1016\/S0020-7292(96)80003-8"},{"key":"4199_CR24","doi-asserted-by":"publisher","unstructured":"Melese MF, Badi MB, Aynalem GL. Perinatal outcomes of severe preeclampsia\/eclampsia and associated factors among mothers admitted in Amhara Region referral hospitals, North West Ethiopia, 2018. BMC Res Notes, 2019;12:147(2019). https:\/\/doi.org\/10.1186\/s13104-019-4161-z.","DOI":"10.1186\/s13104-019-4161-z"},{"key":"4199_CR25","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1016\/S0140-6736(02)08778-0","volume":"359","author":"Group T","year":"2002","unstructured":"Group T. Do women with pre-eclampsia, and their babies, benefit from magnesium sulfate? The Magpie Trial: a randomized placebo-controlled trial. Lancet. 2002;359:1877\u201390.","journal-title":"Lancet"},{"key":"4199_CR26","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1016\/j.ajog.2003.12.057","volume":"190","author":"B Msibal","year":"2004","unstructured":"Msibal B. Magnesium sulfate prophylaxis in preeclampsia: lessons learned from recent trials. Am J Obstet Gynecol. 2004;190:1520\u20136.","journal-title":"Am J Obstet Gynecol"},{"key":"4199_CR27","doi-asserted-by":"publisher","first-page":"227","DOI":"10.4274\/tjod.22308","volume":"15","author":"H Rebahi","year":"2018","unstructured":"Rebahi H, Elizabeth-Still M, Faouzi Y, Rhassane El Adib A. Risk factors for eclampsia in pregnant women with preeclampsia and positive neurosensory signs. Turk J Obstet Gynecol. 2018;15:227\u201334.","journal-title":"Turk J Obstet Gynecol"},{"key":"4199_CR28","first-page":"QC18","volume":"10","author":"LO Ajah","year":"2016","unstructured":"Ajah LO, Ozonu NC, Ezeonu PO, Lawani LO, Obuna JA, Onwe EO. The feto-maternal outcome of preeclampsia with severe features and eclampsia in Abakaliki, south-East Nigeria. J Clin Diagn Res. 2016;10:QC18\u201321.","journal-title":"J Clin Diagn Res"},{"key":"4199_CR29","doi-asserted-by":"publisher","unstructured":"Seyom E, Abera M, Tesfaye M, Fentahun N. Maternal and fetal outcome of pregnancy related hypertension in Mettu Karl Referral Hospital, Ethiopia. J Ovarian Res. 2015;8:10. https:\/\/doi.org\/10.1186\/s13048-015-0135-5.","DOI":"10.1186\/s13048-015-0135-5"},{"key":"4199_CR30","unstructured":"Mohammedseid Sl, Megersa TN, Kumbi S, Ayalew MB. Maternal Outcomes of Preeclampsia in an Ethiopian Gynecologic Hospital. Ann Med Health Sci Res. 2017;7:16-21."},{"key":"4199_CR31","unstructured":"Mekbeb T, Ketsela K. Pre-eclampsia\/eclampsia at Yekatit 12 Hospital, Addis Ababa, Ethiopia (1987-1989). East Afr Med J. 1991;68(11):893-9."},{"key":"4199_CR32","unstructured":"Anbesse J, Eyasu M. Maternal and perinatal outcomes of pregnancies complicated by eclampsia at Tikur Anbessa Hospital: A five year retrospective study.\u00a0Ethiop\u00a0J\u00a0\u00a0Reprod Health. 2014;7(1):22-30."},{"key":"4199_CR33","doi-asserted-by":"publisher","first-page":"2766","DOI":"10.18203\/2320-1770.ijrcog20193040","volume":"8","author":"G Gandhi","year":"2019","unstructured":"Gandhi G, Chandnani K. A prospective study of the incidence and outcomes of eclampsia in a tertiary care hospital and teaching institute in India. Int J Reprod, Contracept, Obstet Gynecol. 2019;8:2766.","journal-title":"Int J Reprod, Contracept, Obstet Gynecol"},{"key":"4199_CR34","unstructured":"Gudu W, Bekele D. A prospective review of eclampsia at a regional hospital, Eastern Ethiopia: incidence, clinical\ncorrelates, management and pregnancy outcome. Ethiop Med J, 2018; 56 (2) :125\u2013132."},{"key":"4199_CR35","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s12884-016-1001-1","volume":"16","author":"A Nakimuli","year":"2016","unstructured":"Nakimuli A, Nakubulwa S, Kakaire OOM, Mbalinda SN, Kakande N, et al. The burden of maternal morbidity and mortality attributable to hypertensive disorders in pregnancy: a prospective cohort study from Uganda. BMC Pregnancy Childbirth. 2016;16:205.","journal-title":"BMC Pregnancy Childbirth"},{"key":"4199_CR36","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1111\/jch.13302","volume":"20","author":"XZW Li","year":"2018","unstructured":"Li XZW, Lin JLH, Yang Z, Teng Y, et al. Risk factors for adverse maternal and perinatal outcomes in women with preeclampsia: analysis of 1396 cases. J Clin Hypertens (Greenwich). 2018;20:1049\u201357.","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"4199_CR37","unstructured":"Mir AM, Shaikh S, Khan M, Masud I, Hussain S. Maternal Mortality due to Eclampsia in Khyber Pakhtunkhwa: Identifying Underlying Risk Factors, and Care-seeking Behaviours. J Pak Med Assoc. 2019;69(7):934-8."},{"key":"4199_CR38","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1186\/s12884-017-1507-1","volume":"17","author":"T Grum","year":"2017","unstructured":"Grum T, Seifu A, Abay M, Angesom T. Determinants of pre-eclampsia\/eclampsia among women attending delivery Services in Selected Public Hospitals of Addis Ababa, Ethiopia: a case-control study. BMC Pregnancy Childbirth. 2017;17:307.","journal-title":"BMC Pregnancy Childbirth"},{"key":"4199_CR39","doi-asserted-by":"publisher","first-page":"509","DOI":"10.2147\/IJWH.S47056","volume":"5","author":"G Guerrier","year":"2013","unstructured":"Guerrier G, Oluyide B, Keramarou M, Grais RF. Factors associated with severe preeclampsia and eclampsia in Jahun, Nigeria. Int J Women's Health. 2013;5:509\u201313.","journal-title":"Int J Women's Health"},{"key":"4199_CR40","doi-asserted-by":"crossref","unstructured":"Pradhan T, Rijal P, Rai R, Bhatta RD, Thapa BD, Regmi MC, et al. Adverse Maternal and Fetal Outcome in Patients with Eclampsia. J Nepal Health Res Counc. 2019; 16(41):425-427.","DOI":"10.33314\/jnhrc.v16i41.1159"},{"issue":"9","key":"4199_CR41","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/S1474-4422(15)00111-8","volume":"14","author":"JE Fugate","year":"2015","unstructured":"Fugate JE, Rabinstein AA. Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions. Lancet Neurol. 2015;14(9):914\u201325.","journal-title":"Lancet Neurol"},{"issue":"1","key":"4199_CR42","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1161\/HYPERTENSIONAHA.113.01667","volume":"63","author":"WG Janzarik","year":"2014","unstructured":"Janzarik WG, Ehlers E, Ehmann R, Gerds TA, Schork J, Mayer S, et al. Dynamic cerebral autoregulation in pregnancy and the risk of preeclampsia. Hypertension. 2014;63(1):161\u20136.","journal-title":"Hypertension"},{"key":"4199_CR43","doi-asserted-by":"publisher","unstructured":"Bilano VL, Ota E, Ganchimeg T, Mori R, Souza JP. Risk factors of pre-eclampsia\/eclampsia and its adverse outcomes in low- and middle-income countries: a WHO secondary analysis. PLoS One. 2014;9(3):e91198. https:\/\/doi.org\/10.1371\/journal.pone.0091198.","DOI":"10.1371\/journal.pone.0091198"},{"key":"4199_CR44","doi-asserted-by":"publisher","unstructured":"Patel S, Thaker R, Shah P, Majumder S: Study of causes and complications of Intrauterine fetal death (IUFD). Int J Reprod\u00a0Contracept\u00a0Obstet\u00a0Gynecol.\u00a02014;3(4):931-5. https:\/\/doi.org\/10.5455\/2320-1770.ijrcog20141211.","DOI":"10.5455\/2320-1770.ijrcog20141211"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-021-04199-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-021-04199-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-021-04199-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T13:05:46Z","timestamp":1635512746000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-021-04199-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,29]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["4199"],"URL":"https:\/\/doi.org\/10.1186\/s12884-021-04199-1","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,29]]},"assertion":[{"value":"24 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical clearance\/approval was obtained from the ethics committee of the School of Medicine, University of Gondar. With this clearance, formal approval was sought and the permission for conducting the study (official letter) was secured from the administration of UOGCSH and the Department of Gynecology and Obstetrics before commencing the study. \u201cInformed Consent waiver was obtained from the ethics committee of School of Medicine, University of Gondar\u201d (Dr. Abebe Muche, Chair of Ethical Review Board, reference number: 2169\/08\/2020) and hospital directors (Signed and approved on reference number, 2169\/08\/2020). The confidentially of the data gathered was kept and handled during all phases of research activities. We confirm that all methods were performed following the relevant guidelines and regulations (institutional, national, and international).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"734"}}